NEW YORK, Sept. 20, 2021 /PRNewswire-PRWeb/ -- The
Mount Sinai Boards of Trustees today announced leadership updates
that will position the Mount Sinai Health System for future
challenges and opportunities. Kenneth L.
Davis, MD, will continue his role as Chief Executive Officer
of the Health System through the end of 2024, and will remain in a
strategic advisory capacity through 2027 and Dennis S. Charney, MD, will continue in his role
as Anne and Joel Ehrenkranz Dean of
the Icahn School of Medicine at Mount
Sinai (Icahn Mount Sinai) and President for Academic Affairs
of the Health System, responsible for the overall operation of the
School, until the end of 2025. Margaret
Pastuszko, MBA, was appointed President and Chief Operating
Officer of the Mount Sinai Health System, becoming the first women
to be named president of a large academic health system in
New York.
Dr. Davis, who became President and Chief Executive Officer of
The Mount Sinai Medical Center in 2003 and of the Mount Sinai
Health System upon its formation in 2013, has successfully led
Mount Sinai through an era of
unprecedented growth and change, including the creation of the
multi-hospital Health System and the transformation of care
delivery. Dr. Charney, who became Dean of Icahn Mount Sinai in
2007, has built the medical school into a top-ranked national
school renowned not only for its research and innovation but for
the extraordinary care it delivers and the outstanding clinicians
it trains. Both have led arms of the institution during
unprecedented challenges related to the pandemic, empowering
clinical and research teams to implement to new strategies and
discover new breakthroughs during this period.
As President and Chief Operating Officer of the Health System,
Ms. Pastuszko will lead the operation of the Health System,
including establishing, achieving, and exceeding short-and
long-term objectives; maintaining the overall viability of the
Health System; and directing operations and corporate services.
"We are excited to welcome Ms. Pastuszko into her new role and
are gratified that Drs. Davis and Charney will continue to provide
their visionary guidance, counsel, and leadership acumen," said
Richard A. Friedman and James S. Tisch, Co-Chairmen of the Boards of
Trustees of the Mount Sinai Health System. "All three are
extraordinary leaders and we are certain that with this executive
leadership team in place, Mount
Sinai will continue to thrive, to grow, and to pursue
greater equity, service, and innovation remaining steadfast in our
mission to provide compassionate patient care through unrivaled
education, research, and outreach into the many diverse communities
we serve."
"Ms. Pastuszko has provided exemplary leadership and
unassailable strategic guidance in implementing system goals that
have helped Mount Sinai to become
a global leader in health care," said Dr. Davis. "She will bring a
bold vision to this role ensuring that Mount Sinai is well-positioned for the
future."
Ms. Pastuszko joined Mount
Sinai in 2000 as Director of Strategic Planning and
Implementation for Mount Sinai School of Medicine, and has held
positions of increasing responsibility over the years involving
analytics, operations, strategy, and system integration. More
recently, as Executive Vice President, Chief Operating Officer, and
Chief Strategy Officer, Ms. Pastuszko led the Health System's
operational response to the COVID-19 pandemic, including a dramatic
expansion of surge capacity, unprecedented efforts to balance
patient loads, and provision of support to the hardest-hit
hospitals, as well as the vaccination drives for employees and
patients. She has worked to improve access and throughput, optimize
resource allocation, and advance new technologies to enhance care
and operations.
About the Mount Sinai Health System
The Mount Sinai Health System is New York
City's largest academic medical system, encompassing eight
hospitals, a leading medical school, and a vast network of
ambulatory practices throughout the greater New York region. We advance medicine and
health through unrivaled education and translational research and
discovery to deliver care that is the safest, highest-quality, most
accessible and equitable, and the best value of any health system
in the nation. The Health System includes approximately 7,300
primary and specialty care physicians; 13 free-standing
joint-venture centers; more than 410 ambulatory practices
throughout the five boroughs of New York
City, Westchester, and
Long Island; and more than 30
affiliated community health centers. The Mount Sinai Hospital is
ranked in U.S. News & World Report's "Honor Roll" of the top 20
U.S. hospitals and among the top in the nation by specialty: No. 1
in Geriatrics and top 20 in Cardiology/Heart Surgery,
Diabetes/Endocrinology, Gastroenterology/GI Surgery,
Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery,
Urology, and Rehabilitation. Mount Sinai Kravis Children's Hospital
is ranked in U.S. News & World Report's "Best Children's
Hospitals" among the country's best in four out of 10 pediatric
specialties. New York Eye and Ear Infirmary of Mount Sinai is ranked among the Top 20
nationally for ophthalmology. The Icahn School of Medicine at
Mount Sinai is one of three
medical schools that have earned distinction by multiple
indicators: ranked in the top 20 by U.S. News & World Report's
"Best Medical Schools," aligned with a U.S. News & World Report
"Honor Roll" Hospital, and No. 14 in the nation for National
Institutes of Health funding. Newsweek's "The World's Best Smart
Hospitals" ranks The Mount Sinai Hospital as No. 1 in New York and top five globally, and Mount
Sinai Morningside as top 20 globally, and "The World's Best
Specialized Hospitals" ranks Mount Sinai Heart as No. 1 in
New York and No. 5 globally and
the Division of Gastroenterology as No. 5 globally. For more
information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and
YouTube.
Media Contact
Lucia Lee, Mount Sinai Health
System, 212-241-9200, NewsMedia@mssm.edu
SOURCE Mount Sinai Health System